289 related articles for article (PubMed ID: 28379443)
1. Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system.
Takayanagi S; Mukasa A; Tanaka S; Nomura M; Omata M; Yanagisawa S; Yamamoto S; Ichimura K; Nakatomi H; Ueki K; Aburatani H; Saito N
Neuro Oncol; 2017 Sep; 19(9):1228-1236. PubMed ID: 28379443
[TBL] [Abstract][Full Text] [Related]
2. Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity.
Gijtenbeek JM; Jacobs B; Sprenger SH; Eleveld MJ; van Kessel AG; Kros JM; Sciot R; van Calenbergh F; Wesseling P; Jeuken JW
J Neurosurg; 2002 Oct; 97(4):977-82. PubMed ID: 12405390
[TBL] [Abstract][Full Text] [Related]
3. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
[TBL] [Abstract][Full Text] [Related]
4. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas.
Tse JY; Wong JH; Lo KW; Poon WS; Huang DP; Ng HK
Am J Clin Pathol; 1997 Apr; 107(4):459-66. PubMed ID: 9124215
[TBL] [Abstract][Full Text] [Related]
6. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
[TBL] [Abstract][Full Text] [Related]
7. Hemangioblastomas and Other Vascular Origating Tumors of Brain or Spinal Cord.
Vetrano IG; Gioppo A; Faragò G; Pinzi V; Pollo B; Broggi M; Schiariti M; Ferroli P; Acerbi F
Adv Exp Med Biol; 2023; 1405():377-403. PubMed ID: 37452946
[TBL] [Abstract][Full Text] [Related]
8. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
Richard S; Martin S; David P; Decq P
Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterisation of sporadic endolymphatic sac tumours and comparison to von Hippel-Lindau disease-related tumours.
Schweizer L; Thierfelder F; Thomas C; Soschinski P; Kim HY; Jödicke R; Woltering N; Förster A; Teichmann D; Siewert C; Klein K; Schmid S; Nunninger M; Thomale UW; Onken J; Mühleisen H; Schittenhelm J; Tatagiba M; von Deimling A; Reuss DE; Solomon DA; Heppner FL; Koch A; Hartmann C; Staszewski O; Capper D
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):756-767. PubMed ID: 34091929
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups.
Woltering N; Albers A; Müther M; Stummer W; Paulus W; Hasselblatt M; Holling M; Thomas C
Brain Pathol; 2022 Nov; 32(6):e13083. PubMed ID: 35637626
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at 6q is frequent and concurrent with 3p loss in sporadic and familial capillary hemangioblastomas.
Lemeta S; Pylkkänen L; Sainio M; Niemelä M; Saarikoski S; Husgafvel-Pursiainen K; Böhling T
J Neuropathol Exp Neurol; 2004 Oct; 63(10):1072-9. PubMed ID: 15535134
[TBL] [Abstract][Full Text] [Related]
13. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
[TBL] [Abstract][Full Text] [Related]
14. Variable response of CNS hemangioblastomas to Pazopanib in a single patient with von Hippel-Lindau disease: Case report.
Taylor DG; Ilyas A; Mehta GU; Chen CJ; Schiff D; Oldfield EH; Asthagiri AR
J Clin Neurosci; 2018 Apr; 50():154-156. PubMed ID: 29396065
[TBL] [Abstract][Full Text] [Related]
15. Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel-Lindau disease: case report.
Liu Z; Zhou J; Li L; Yi Z; Lu R; Li C; Gong K
BMC Med Genet; 2020 Oct; 21(1):191. PubMed ID: 33004005
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity reveals non-VHL allelic loss in hemangioblastomas at 22q13.
Beckner ME; Sasatomi E; Swalsky PA; Hamilton RL; Pollack IF; Finkelstein SD
Hum Pathol; 2004 Sep; 35(9):1105-11. PubMed ID: 15343513
[TBL] [Abstract][Full Text] [Related]
17. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
Yousef A; Rutkowski MJ; Yalcin CE; Eren OC; Caliskan I; Tihan T
J Neurooncol; 2019 Jul; 143(3):547-552. PubMed ID: 31089924
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M
Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849
[TBL] [Abstract][Full Text] [Related]
19. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
[TBL] [Abstract][Full Text] [Related]
20. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
